“…However, multiple RCTs testing the OLA in ARDS patients have failed to show significant benefits over standard of care (Brower et al, 2004;Meade et al, 2008;Mercat et al, 2008;Cavalcanti et al, 2017;Hodgson et al, 2019). Reasons for these failures include the following: (1) timing of OLA application [early (Borges et al, 2006) vs. late (Gattinoni et al, 2006)] (2) onesize-fits-all RM strategies, (3) PEEP set inappropriately to keep the recruited lung open, (4) recruiting pressures insufficient to open all of the lung, (5) a patient population of responders (lung recruits) and non-responders (lung does not recruit) (Gattinoni et al, 2006), and (6) application of OLA not as a continuous treatment but rather as a one-time event with a long time period before a second application or with no second application at all (Goligher et al, 2017;Lu et al, 2017;Bhattacharjee et al, 2018;Cui et al, 2019;Hodgson et al, 2019;Kang et al, 2019;van der Zee and Gommers, 2019;Zheng et al, 2019). Most (Bhattacharjee et al, 2018;Cui et al, 2019;Hodgson et al, 2019;Kang et al, 2019;Zheng et al, 2019) but not all (Goligher et al, 2017;Lu et al, 2017) meta-analyses have shown no decrease in ARDS-related mortality associated with the OLA.…”